InvestorsHub Logo
Followers 120
Posts 19685
Boards Moderated 0
Alias Born 08/27/2005

Re: NASDAQ2020 post# 284378

Wednesday, 02/21/2018 11:47:45 PM

Wednesday, February 21, 2018 11:47:45 PM

Post# of 410858
And just wait until Elite gets their better Embeda, which will not leak due to additional Naltrexone.... AND the rush from snorting will be reduced by up to seven fold with Elite's single bead version.

Current Embeda can probably be compared to APAPs which are readily abused.
FDA may have to rethink the APAP situation. Lots of abusers abusing Percocet and Norco. Acetaminophen doesn't do much to deter abuse, just as the minimal amount of naltrexone will not do much to deter abuse of morphine in current Embeda.

Eventually FDA will have to move on both Embeda and APAPs IMO. Elite has the ADF for both.
Already did the studies needed for the APAPs. So if the FDA ever decides to go Percocet with Naltrexone Elite will be there locked and loaded.

As for Embeda.... Elite's version is superior to the current version. Just my opinion now. Others may feel the original Embeda is good the way it is.
Less naltrexone..... more abused.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News